ASP 6858

Drug Profile

ASP 6858

Alternative Names: ASP6858

Latest Information Update: 27 May 2016

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Astellas Pharma
  • Class Urologics
  • Mechanism of Action Undefined mechanism
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity Yes

Highest Development Phases

  • Discontinued Renal failure

Most Recent Events

  • 11 May 2016 Discontinued - Phase-I for Renal failure (In volunteers) in United Kingdom (PO)
  • 06 Oct 2015 Astellas Pharma restarts enrolment in a phase I trial in Healthy volunteers in United Kingdom (NCT02359032)
  • 06 Aug 2015 Astellas Pharma suspends a phase I trial in Healthy volunteers in United Kingdom due to operational reasons (PO) (NCT02359032)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top